RxDoctor Payments Data

Ian Kaye, MD

Orthopaedic Surgery · Mercerville, NJNPI 1205128220

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.3%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by The Institute Of Musculoskeletal Science And Education at 50.5% of the total. 2025 is the largest year on record at $17,461, more than ten times the $1,339 reported in 2019.

$42,132in general payments, 2019–2025

Across 67 payments — averaging $628.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$21K
  • Globus Medical$13K
  • Camber Spine Technologies LLC$4K
  • Medical Device Business Services, Inc.$2K
  • Stryker$1K
  • Nevro Corp.$310
  • plus $770 from 8 others
$49,998in ownership & investment interests, 2019–2025

Across 3 payments — averaging $16,666 each. An ownership or investment interest held by the physician or an immediate family member.

  • Happe Spine$50K

What the payments were for

  • Royalty or licence$15,08236%
  • Consulting fees$20,79049%
  • Travel & lodging$4,14810%
  • Food & beverage$2,1115%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,132 in reported general payments places this provider in the 85th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$287,091
Medicare patients
458
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin114$1,079
Cyclobenzaprine Hcl56$536
Celecoxib24$224
Methylprednisolone24$128
Meloxicam34$65
Tramadol Hcl23$50

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Mercerville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →